Security National Bank Buys Shares of 300 iShares Biotechnology ETF $IBB

Security National Bank bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 300 shares of the financial services provider’s stock, valued at approximately $38,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Apollon Wealth Management LLC boosted its stake in iShares Biotechnology ETF by 1.1% in the first quarter. Apollon Wealth Management LLC now owns 8,754 shares of the financial services provider’s stock valued at $1,120,000 after acquiring an additional 96 shares during the period. SBI Securities Co. Ltd. boosted its stake in iShares Biotechnology ETF by 5.2% in the first quarter. SBI Securities Co. Ltd. now owns 2,198 shares of the financial services provider’s stock valued at $281,000 after acquiring an additional 108 shares during the period. Wealthcare Advisory Partners LLC boosted its stake in iShares Biotechnology ETF by 1.1% in the first quarter. Wealthcare Advisory Partners LLC now owns 10,651 shares of the financial services provider’s stock valued at $1,362,000 after acquiring an additional 111 shares during the period. Fischer Financial Services Inc. boosted its stake in iShares Biotechnology ETF by 0.6% in the first quarter. Fischer Financial Services Inc. now owns 21,608 shares of the financial services provider’s stock valued at $2,764,000 after acquiring an additional 125 shares during the period. Finally, Larson Financial Group LLC boosted its stake in iShares Biotechnology ETF by 8.7% in the first quarter. Larson Financial Group LLC now owns 1,906 shares of the financial services provider’s stock valued at $244,000 after acquiring an additional 153 shares during the period. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $143.63 on Friday. The business has a 50 day moving average of $136.53 and a two-hundred day moving average of $129.31. iShares Biotechnology ETF has a 52 week low of $107.43 and a 52 week high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 19th. Stockholders of record on Tuesday, September 16th will be given a dividend of $0.0828 per share. The ex-dividend date is Tuesday, September 16th. This represents a $0.33 annualized dividend and a dividend yield of 0.2%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.